The Worldwide Poultry Vaccines Industry is Expected to Reach $2.8 Billion by 2028 - ResearchAndMarkets.com

The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, June 29, 2022
Information
Tags: 
Pharmaceutical, Health, COVID-19, Agriculture, Salmonella, Transport, Government of Japan, Chicken, Administration, North American Meat Institute, Immunization, Meat, Poultry, Education, Poultry Products Inspection Act of 1957, Personal protective equipment, Credit, Campylobacter, COVID-19, Center, American Meat Institute, Industry, Centers for Disease Control and Prevention timeline, Foodborne illness, Ventilation, GOJ, Advisory Committee, Restaurant, ACIP, CAGR, Health, Human, Animal, Temperature, Farmer, Infection, Vaccine, Vaccination, Safety, Dosage form, Severe acute respiratory syndrome coronavirus 2, Veterinarian, HPAI, Social media, CDC, Route of administration, EMEA, Livestock, Technology, Disease
Geotags: 
USA, EUROPE, INDIA, JAPAN
Summary
Key Points: 
  • The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.
  • Rumors spread on social media about poultry birds being possible vectors of SARS-CoV-2 further hampered the demand for poultry products.
  • With the rise in demand for poultry food products, the need for vaccines is on the rise to keep poultry safe and achieve optimum yields.
  • Poultry birds are susceptible to various fowl illnesses, which cause significant economic losses to the business, particularly in poorer nations.


The "Global Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Technology, Dosage Form, Disease, Route of Administration, End User" report has been added to ResearchAndMarkets.com's offering.

The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The COVID-19 pandemic and the associated lockdown for a long period led to significant adversities in different sectors, including the agriculture and other allied sub-sectors in India and several other countries.

The members of the North American Meat Institute process the great majority of beef, pig, lamb, and poultry produced in the US, which is required to make the safest and finest quality meat and poultry products. According to federal guidance approved by the Advisory Committee on Immunization Priority (ACIP) of the Centers for Disease Control (CDC), frontline meat and poultry workers should be the next priority for COVID-19 vaccination, after the healthcare workers. Members of the meat institute have distributed numerous pieces of personal protective equipment, implemented health and temperature screening, drastically altered facilities, conducted testing, provided paid preemptive leaves for high-risk and quarantined employees, and improved air sanitation and ventilation. Due to these safety measures, COVID-19 infection rates are now more than 8-times lower among meat and poultry workers than in the general population. However, limited processing capacity for poultry has negatively impacted the distribution and retail of animal products in the US.

The shutdown of teaching and training institutes, competition and event venues, tourist places, and trade and sales facilities has led to a drop in demand for poultry vaccines. Chickens are not sensitive to SARS-CoV-2 infection, i.e., COVID-19. Nonetheless, the COVID-19 pandemic had an impact on poultry consumption, transportation, and farming economics. Stockholders, veterinarians, farmers, and the entire poultry production chain partners need to be more involved in the current situation to fulfill consumer demands and ensure sustainable agriculture. According to a recent report prepared by P W Cargill, Merial Avian Business Unit UK and Joey Johnston, Merial Avian Business Unit, USA 2021, although the pandemic disrupted the poultry industry in Europe in 2020, it is expected to resurge in 2021.

Amid the COVID-19 crisis, in June 2020, the Government of Japan (GOJ) declared a state of emergency and asked people to stay home. During these lockdowns, the demand for poultry meat gone down due to the shuttering of restaurants. According to Investment Information and Credit Rating Agency of India Limited, the poultry industry in India suffered great losses during the recent lockdown with Q4 FY2020 being the worst quarter in 2020. The industry incurred huge losses due to a sharp decline in sales, demand, realization, and profitability. Rumors spread on social media about poultry birds being possible vectors of SARS-CoV-2 further hampered the demand for poultry products. In January 2021, the largest bird flu outbreak in years hit chicken farmers in Asian countries, including Japan to India, further upsetting poultry prices. Since November 2020, more than 20 million chickens have been destroyed in South Korea and Japan.

The growing demand for healthy chicken food in Europe, the Middle East & Africa (EMEA) encourages governments to create suitable laws and regulations for the safety of animals in the poultry business. For example, infections with Campylobacter and Salmonella species are the two most common foodborne illnesses caused by eating chicken meat. The instances of influenza H5N1 infection in humans are linked to the consumption of raw or undercooked chicken or chicken products (HPAI). Based on demands, there has been a rise in the production of poultry products in the EMEA. With the rise in demand for poultry food products, the need for vaccines is on the rise to keep poultry safe and achieve optimum yields. However, the demand is decreasing in the poorer African countries. Poultry birds are susceptible to various fowl illnesses, which cause significant economic losses to the business, particularly in poorer nations.

Market Dynamics

Drivers

  • Increasing Prevalence of Diseases in Poultry
  • Increasing Demand for Healthy Poultry Food

Restraints

  • Failure of Vaccines in Poultry Production

Opportunities

  • Rising Growth of Market in Untapped Economies

Future Trends

  • Key Business Strategies to Enhance Market Growth in Future

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Ceva Sante Animale
  • BIOVAC
  • Phibro Animal Health Corporation
  • Hester Biosciences Limited
  • Venky's India
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Merck Animal Health

For more information about this report visit https://www.researchandmarkets.com/r/ucjimr

Copyright: 
Copyright Business Wire 2022